C

Cadrenal Therapeutics Inc
NASDAQ:CVKD

Watchlist Manager
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Watchlist
Price: 15.68 USD 2.15%
Market Cap: 30.4m USD

Intrinsic Value

CVKD's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one CVKD stock under the Base Case scenario is 5.16 USD. Compared to the current market price of 15.68 USD, Cadrenal Therapeutics Inc is Overvalued by 67%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CVKD Intrinsic Value
5.16 USD
Overvaluation 67%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Cadrenal Therapeutics Inc

Valuation History Unavailable

Historical valuation for CVKD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Cadrenal Therapeutics Inc
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Cadrenal Therapeutics Inc

Balance Sheet Decomposition
Cadrenal Therapeutics Inc

Current Assets 10.1m
Cash & Short-Term Investments 10m
Receivables 38.2k
Other Current Assets 56.7k
Non-Current Assets 10.7k
PP&E 6.9k
Other Non-Current Assets 3.8k
Efficiency

Free Cash Flow Analysis
Cadrenal Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cadrenal Therapeutics Inc

Revenue
0 USD
Operating Expenses
-11m USD
Operating Income
-11m USD
Other Expenses
309.2k USD
Net Income
-10.7m USD
Fundamental Scores

CVKD Profitability Score
Profitability Due Diligence

Cadrenal Therapeutics Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROIC
Negative Free Cash Flow
Negative Operating Income
47/100
Profitability
Score

Cadrenal Therapeutics Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

CVKD Solvency Score
Solvency Due Diligence

Cadrenal Therapeutics Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
59/100
Solvency
Score

Cadrenal Therapeutics Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CVKD Price Targets Summary
Cadrenal Therapeutics Inc

Wall Street analysts forecast CVKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVKD is 36.38 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.

Lowest
Price Target
30.3 USD
93% Upside
Average
Price Target
36.38 USD
132% Upside
Highest
Price Target
47.25 USD
201% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cadrenal Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CVKD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CVKD Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CVKD stock?

The intrinsic value of one CVKD stock under the Base Case scenario is 5.16 USD.

Is CVKD stock undervalued or overvalued?

Compared to the current market price of 15.68 USD, Cadrenal Therapeutics Inc is Overvalued by 67%.

Back to Top